Table 1.

Patient demographics and results

Patient	Age (years)	Sex	Diagnosis	Target lesion		[18F]Fluciclatide SUV80% max	Uptake ratios		Ki	Immunohistochemistry
				Location	Size (cm)		Tumor- to-blood	Tumor- to-muscle		αvβ3	αvβ5
1	36	F	Metastatic melanoma	Small-bowel jejunum	2.6	3.7	0.7	4.8	0.0037	0.29	0.16
2	32	F	Metastatic melanoma	Upper back soft tissue	4.1	1.8	0.6	2.8	0.0032	0.31	0.06
3	57	M	Metastatic melanoma	Left occipital	2.5	0.7	0.2	0.8	0.0014	Not measured	0.06
4	49	F	Metastatic melanoma	Left supraclavicular	4.1	6.5	1.4	12	0.0083	0.31	0.23
5	56	F	Metastatic melanoma	Left axilla	4.5	3.3	0.9	4	0.0070	0.32	0.32
6	59	M	Metastatic melanoma	Anterior chest wall	2.6	2.1	0.4	2.6	0.0032	0.20	0.17
7	62	M	Oncocytoma	Left kidney	9.0	9.2	2.7	11	0.016	0.36	0.14
8	54	F	RCC, chromophobe	Left kidney	3.8	8.1	1.6	8.7	0.011	0.16	0.25
9	57	M	RCC, chromophobe	Right kidney	3.1	5.8	1.9	7.6	0.017	0.13	0.29
10	50	F	RCC, chromophobe	Right kidney	3.1	8.9	1.6	12.8	0.013	0.23	0.22
11	60	M	RCC, chromophobe	Right kidney	5.2	10.0	2.6	11.6	0.018	0.27	0.27
12	56	M	RCC, clear cell	Left kidney	3.6	6.1	1.2	3.4	0.0052	0.11	0.04
13	57	M	RCC, clear cell	Right kidney	3.5	6.5	1.3	6.3	0.0066	0.22	0.10
14	48	M	RCC, clear cell	Right kidney	3.2	7.8	1.4	13.6	0.0049	0.12	0.10
15	47	M	RCC, clear cell	Retroperitoneal	5.0	4.5	1.3	9.4	0.0073	0.11	0.17
16	53	M	RCC, clear cell, metastatic	Left kidney	5.6	3.8	1.1	3.7	0.0068	0.06	0.09
17	24	F	RCC, clear cell	Left kidney	3.6	4.2	1.1	6.1	0.0081	0.28	0.11
18	59	M	RCC, papillary	Right kidney	6.8	5.0	1.3	10.3	0.0057	0.06	0.04